Ohio State study suggests that dopamine is a safe anti-angiogenic drug in cancer treatment

A new study led by scientists at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that dopamine – an inexpensive drug currently used to treat heart, vascular and kidney disorders – can be safely used in cancer treatment to curb … Continue reading “Ohio State study suggests that dopamine is a safe anti-angiogenic drug in cancer treatment”

A new study led by scientists at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) suggests that dopamine – an inexpensive drug currently used to treat heart, vascular and kidney disorders – can be safely used in cancer treatment to curb the growth of blood vessels in tumors.

Click here to read the full press release.

###

Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply